• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在住院患者中,COVID-19 感染严重程度期间 IFN-γ 的表达显著降低。

Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients.

机构信息

Department of Microbiology, Faculty of Science & Technology, University of Central Punjab, Lahore, Pakistan.

Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.

出版信息

PLoS One. 2023 Sep 27;18(9):e0291332. doi: 10.1371/journal.pone.0291332. eCollection 2023.

DOI:10.1371/journal.pone.0291332
PMID:37756264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10530045/
Abstract

Cytokines play an important role in SARS-CoV-2 infection progression and severity. A number of inflammatory cytokines have been directly associated with disease severity including IL-6 (interleukin-6), IL-10, TNF-α (tumor necrosis factor alpha), IFN-γ (interferon-gamma). Here, in this study, the aim was to better understand the interplay between host immune response mediated by cytokines and severity of SARS-CoV-2 infection by assessing cytokine expression. Therefore, we measured expression levels of a total of 12 genes (IFNA-1, IFN-γ, IL-1α, IL-1β, IL-4, IL-6, IL-7, IL-10, IL-11, IL-13, IL-15, and IL-27) encoding inflammatory, anti-inflammatory and regulatory cytokines using QRT-PCR in hospitalized patients with severe infection compared to mildly infected. IFN-γ was identified as a potent marker of disease severity as indicated previously. Moreover, levels of IL-7 were also found to be partially reduced in patients compared to the healthy controls and linked negatively to disease severity. Identification of these cytokines may be helpful in not only understanding disease pathogenesis but also in better management of the patients after covid infection.

摘要

细胞因子在 SARS-CoV-2 感染的进展和严重程度中起着重要作用。许多炎症细胞因子与疾病的严重程度直接相关,包括白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-γ)。在这里,在这项研究中,目的是通过评估细胞因子的表达来更好地了解细胞因子介导的宿主免疫反应与 SARS-CoV-2 感染严重程度之间的相互作用。因此,我们使用 QRT-PCR 测量了住院严重感染患者与轻度感染患者相比,总共 12 种基因(IFNA-1、IFN-γ、IL-1α、IL-1β、IL-4、IL-6、IL-7、IL-10、IL-11、IL-13、IL-15 和 IL-27)的表达水平,这些基因编码炎症、抗炎和调节性细胞因子。IFN-γ 被鉴定为疾病严重程度的有力标志物,如前所述。此外,与健康对照组相比,患者的 IL-7 水平也发现部分降低,并且与疾病严重程度呈负相关。鉴定这些细胞因子不仅有助于了解疾病发病机制,还有助于更好地管理新冠病毒感染后的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfe/10530045/c511deec9df3/pone.0291332.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfe/10530045/b3daa911e93e/pone.0291332.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfe/10530045/713d450aeb77/pone.0291332.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfe/10530045/c511deec9df3/pone.0291332.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfe/10530045/b3daa911e93e/pone.0291332.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfe/10530045/713d450aeb77/pone.0291332.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfe/10530045/c511deec9df3/pone.0291332.g003.jpg

相似文献

1
Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients.在住院患者中,COVID-19 感染严重程度期间 IFN-γ 的表达显著降低。
PLoS One. 2023 Sep 27;18(9):e0291332. doi: 10.1371/journal.pone.0291332. eCollection 2023.
2
High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.在康复和长新冠患者的体外全血细胞因子释放试验(CRA)中发现高水平的促炎 SARS-CoV-2 特异性生物标志物。
PLoS One. 2023 Apr 5;18(4):e0283983. doi: 10.1371/journal.pone.0283983. eCollection 2023.
3
Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.非住院轻/中度 COVID-19 感染患者的促炎和抗炎细胞因子的血清谱。
Immunol Lett. 2023 Aug;260:24-34. doi: 10.1016/j.imlet.2023.06.008. Epub 2023 Jun 18.
4
Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.血清 IL-23、IL-10 和 TNF-α 可预测 COVID-19 患者的住院死亡率。
Front Immunol. 2023 May 22;14:1145840. doi: 10.3389/fimmu.2023.1145840. eCollection 2023.
5
Proinflammatory Cytokine Profiles in Both Mild Symptomatic and Asymptomatic SARS-CoV-2-Infected Egyptian Individuals and a Proposed Relationship to Post-COVID-19 Sequela.埃及轻症和无症状 SARS-CoV-2 感染个体的促炎细胞因子谱与新冠后后遗症的相关性研究
Viral Immunol. 2023 Nov;36(9):600-609. doi: 10.1089/vim.2023.0060. Epub 2023 Oct 13.
6
Characterization of the inflammatory response to COVID-19 illness in pregnancy.探讨 COVID-19 疾病在妊娠期间引发的炎症反应特征。
Cytokine. 2023 Oct;170:156319. doi: 10.1016/j.cyto.2023.156319. Epub 2023 Aug 4.
7
A Specific Pattern and Dynamics of Circulating Cytokines Are Associated with the Extension of Lung Injury and Mortality in Colombian Adults with Coronavirus Disease-19.循环细胞因子的特定模式和动态与哥伦比亚成年 COVID-19 患者肺损伤和死亡率的延长有关。
J Interferon Cytokine Res. 2023 May;43(5):206-215. doi: 10.1089/jir.2023.0001. Epub 2023 Apr 27.
8
Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection.促炎细胞因子 CXCL-10、TNF-α、IL-1β 和 IL-6:SARS-CoV-2 感染的生物标志物。
Arch Virol. 2021 Dec;166(12):3301-3310. doi: 10.1007/s00705-021-05247-z. Epub 2021 Sep 23.
9
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.严重 COVID-19 中促炎细胞因子特征的描述。
Front Immunol. 2023 Mar 30;14:1170012. doi: 10.3389/fimmu.2023.1170012. eCollection 2023.
10
Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae.细胞因子和脂肪因子谱对住院 COVID-19 患者的预测作用:疾病严重程度、生存和肺部后遗症的评估。
Int J Mol Sci. 2023 Aug 20;24(16):12994. doi: 10.3390/ijms241612994.

引用本文的文献

1
Identification of severity related mutation hotspots in SARS-CoV-2 using a density-based clustering approach.使用基于密度的聚类方法识别新冠病毒中与严重程度相关的突变热点。
BioData Min. 2025 Sep 1;18(1):61. doi: 10.1186/s13040-025-00476-3.
2
Distinctive Temporal Profiles of Interferon-Stimulated Genes in Natural Infection, Viral Challenge, and Vaccination.自然感染、病毒攻击和疫苗接种中干扰素刺激基因的独特时间特征
Viruses. 2025 Jul 29;17(8):1060. doi: 10.3390/v17081060.
3
Systemic immune response alteration in patients with severe pressure ulcers.

本文引用的文献

1
The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.IL-1 家族细胞因子及其受体在 COVID-19 发病机制中的作用。
Inflamm Res. 2022 Aug;71(7-8):923-947. doi: 10.1007/s00011-022-01596-w. Epub 2022 Jun 25.
2
IL-13 is a driver of COVID-19 severity.IL-13 是导致 COVID-19 严重程度的因素之一。
JCI Insight. 2021 Aug 9;6(15):e150107. doi: 10.1172/jci.insight.150107.
3
Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.白细胞介素-6 是导致致命性严重急性呼吸综合征冠状病毒 2 型肺炎的生物标志物。
严重压疮患者的全身免疫反应改变
Sci Rep. 2025 Jun 4;15(1):19579. doi: 10.1038/s41598-025-04710-0.
4
Attenuated interferon-γ following injury is associated with chronic critical illness.损伤后干扰素-γ减弱与慢性危重病相关。
J Trauma Acute Care Surg. 2025 Jun 3. doi: 10.1097/TA.0000000000004671.
5
[Innate immune response to interferon gamma in severe Covid-19 positive patients].[重症新冠病毒阳性患者对干扰素γ的先天性免疫反应]
Rev Med Inst Mex Seguro Soc. 2025 Mar 3;63(2):e6353. doi: 10.5281/zenodo.14617070.
6
Prospective Variation of Cytokine Trends during COVID-19: A Progressive Approach from Disease Onset until Outcome.COVID-19 期间细胞因子趋势的前瞻性变化:从发病到结局的递进方法。
Int J Mol Sci. 2024 Oct 1;25(19):10578. doi: 10.3390/ijms251910578.
7
IRF1 Mediates Growth Arrest and the Induction of a Secretory Phenotype in Alveolar Epithelial Cells in Response to Inflammatory Cytokines IFNγ/TNFα.IRF1 介导肺泡上皮细胞在炎症细胞因子 IFNγ/TNFα 作用下的生长停滞和分泌表型的诱导。
Int J Mol Sci. 2024 Mar 19;25(6):3463. doi: 10.3390/ijms25063463.
8
Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection.干扰素在抗病毒斗争中的作用:从病毒-宿主相互作用到 SARS-CoV-2 感染的预防和治疗潜力。
Front Immunol. 2024 Jan 15;14:1273604. doi: 10.3389/fimmu.2023.1273604. eCollection 2023.
9
Identification of the feature genes involved in cytokine release syndrome in COVID-19.鉴定 COVID-19 中细胞因子释放综合征相关的特征基因。
PLoS One. 2024 Jan 2;19(1):e0296030. doi: 10.1371/journal.pone.0296030. eCollection 2024.
Front Immunol. 2021 Feb 18;12:613422. doi: 10.3389/fimmu.2021.613422. eCollection 2021.
4
Cytokine Storm.细胞因子风暴
N Engl J Med. 2020 Dec 3;383(23):2255-2273. doi: 10.1056/NEJMra2026131.
5
Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.循环白细胞介素-6 和白细胞介素-10 水平,而不是肿瘤坏死因子-α,作为 COVID-19 严重程度和死亡率的潜在生物标志物:系统评价与荟萃分析。
J Clin Immunol. 2021 Jan;41(1):11-22. doi: 10.1007/s10875-020-00899-z. Epub 2020 Oct 31.
6
Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.评估 COVID-19 合并巨噬细胞活化综合征和急性呼吸窘迫综合征患者的α防御素、白细胞介素-1 受体拮抗剂和白细胞介素-18 水平。
J Med Virol. 2021 Apr;93(4):2090-2098. doi: 10.1002/jmv.26589. Epub 2020 Oct 30.
7
An inflammatory cytokine signature predicts COVID-19 severity and survival.炎症细胞因子特征可预测 COVID-19 严重程度和存活情况。
Nat Med. 2020 Oct;26(10):1636-1643. doi: 10.1038/s41591-020-1051-9. Epub 2020 Aug 24.
8
Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19.动态白细胞介素-6水平变化作为COVID-19患者的预后指标
Front Pharmacol. 2020 Jul 17;11:1093. doi: 10.3389/fphar.2020.01093. eCollection 2020.
9
Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient.对一名重症COVID-19患者进行白细胞介素-7同情用药的免疫监测。
Cell Mol Immunol. 2020 Sep;17(9):1001-1003. doi: 10.1038/s41423-020-0516-6. Epub 2020 Jul 29.
10
Longitudinal analyses reveal immunological misfiring in severe COVID-19.纵向分析揭示了重症 COVID-19 中的免疫失调。
Nature. 2020 Aug;584(7821):463-469. doi: 10.1038/s41586-020-2588-y. Epub 2020 Jul 27.